CHICAGO, Dec. 28 /PRNewswire-FirstCall/ -- The Female Health Company today announced that executives will host an investor conference call to discuss the operating results for the fourth quarter and year ended September 30, 2005. The Company plans to report its fourth quarter operating results December 29, 2005. An investor conference call has been scheduled for 11:00 a.m. Eastern Standard Time on January 3, 2006, in order to allow interested participants to return from holiday activities.
Shareholders and other interested parties may participate in the conference call by dialing 800-865-4435 (international dial 973-935-2404) and referencing the conference ID 6828491, a few minutes before 11:00 a.m. EST on January 3, 2006. A replay of the call will be available through January 10, 2006 by dialing 877-519-4471 (international callers dial 973-341-3080), and entering the conference ID 6828491.
The Company requests that shareholders and other interested parties pre-submit questions for the conference call by emailing such questions to the Company at, FHCInvestor@aol.com.
About The Female Health Company, Inc.
The Female Health Company, based in Chicago, owns certain worldwide rights to FC Female Condom(R) including patents which have been issued in the United States, United Kingdom, Japan, France, Italy, Germany, Spain, The People’s Republic of China, Canada, New Zealand, South Korea and Australia. FC Female Condom(R) is the only available product controlled by a woman that protects against sexually transmitted diseases including HIV/AIDS, and unintended pregnancy.
For more information about the Female Health Company, dial toll-free via fax, 1-800-PRO-INFO and enter company code “FHCO”. Also, visit the Company’s web site at http://www.femalehealth.com and http://www.femalecondom.org . If you would like to be added to an e-mail alert list, please send an e-mail to FHCInvestor@aol.com .
The Female Health Company, Inc.
CONTACT: Investors, William R. Gargiulo, Jr., +1-231-526-1244, for TheFemale Health Company, Inc.
